UTokyo Innovation Platform has scored an exit as the online investment platform developer went public on the Tokyo Stock Exchange.

The Sinopharm-backed antimicrobial drug developer received $107m in a Legend Capital-led round that took its overall funding to $255m.

Lilly Asia Ventures owns more than 9% of the cancer cell therapy developer, which has set a preliminary target of $100m for its initial public offering.

Microsoft and Google participated in a round for the news aggregator's parent company, Verse Innovation, that will support its short-form video app.

Sunshine Insurance Group and existing backer Tencent both took part in a series D round that took the medical management software provider's total funding past $115m.

Strive led a $19.3m round for the construction drone software developer that included Canal Ventures, Delight Ventures, Japan Post Capital, Kashiwabara, Makoto Capital and Mizuho Capital.

In the second half of out 2020 roundup we look at growth areas including digital health and health insurance, online education platforms and financial technology.

Q&A with Aldi Adrian Hartanto, vice-president of investments, MDI Ventures

SIG Asia-backed pet lifestyle goods provider has secured funding in a round led by ClearVue Partners with the aim of driving international expansion.

Tencent co-led a series E1 round for the cancer drug development services provider, which counts China Electronics Corporation and Ping An as earlier investors.